and Healthcare Industry Group
-
- 41,400 Million
- FY2023 Revenue
-
- 2,011 Million
- FY2023 Net Profit after deducting extraordinary gain or loss attributable to owners of the parent
-
- 5,937 Million
- FY2023 R&D Expenditure
-
- 40,370
- Global Employees
-
- Five-Star (Excellence)
- 2022 Corporate Social Responsibility Report Rating
-
- A
- MSCI ESG Rating
Unit: RMB million
-
2022-09-19
Fosun Pharma and Carephar Enter into a Global Collaboration to Co-develop and Exclusively Commercialize China's First Self-Developed P-CAB Product Keverprazan Hydrochloride
(September 19, 2022, Shanghai, China)Shanghai Fosun Pharmaceutical (Group) Co., Ltd.(“Fosun Pharma”, Stock Code: 600196.SH; 02196.HK), a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, announced that its subsidiary Shanghai Fosun Pharmaceutical Industry Development Co. Ltd.
-
2022-09-07
Neovii and Fosun Pharma Enter into an Exclusive Agreement for Development and Commercialization for Grafalon ® in China
(September 7, 2022,Rapperswil,Switzerland and Shanghai, China)Neovii Pharmaceuticals AG(“Neovii”) and Shanghai Fosun Pharmaceutical Industry Development Co. Ltd(“Fosun Pharma Industry”), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
-
2022-08-29
Fosun Pharma Announces 2022 Interim Results Stable Revenue Growth and Recurring Income, Elevating the Revenue Contribution of New Products, and Accelerating International Layout
(August 30, 2022, Shanghai, China) August 29, 2022,Shanghai Fosun Pharmaceutical (Group) Co., Ltd.(“Fosun Pharma” or “the Group”; Stock Code: 600196.SH, 02196.HK), a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, announced its interim results for the first half of 2022.
Dual-Listed on A+H Shares
Sustainable Development
In Pursuit of Sustainable Development of Talents and Products
Fosun Pharma adheres to the concept of "pursuing sustainable development of talents and products", comprehensively practices corporate social responsibility, continuously improves the satisfaction of stakeholders, and is committed to leading the development of social responsibility in the industry.